These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 28564678

  • 1. Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis: A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography.
    Dey AK, Joshi AA, Chaturvedi A, Lerman JB, Aberra TM, Rodante JA, Teague HL, Harrington CL, Rivers JP, Chung JH, Kabbany MT, Natarajan B, Silverman JI, Ng Q, Sanda GE, Sorokin AV, Baumer Y, Gerson E, Prussick RB, Ehrlich A, Green LJ, Lockshin BN, Ahlman MA, Playford MP, Gelfand JM, Mehta NN.
    JAMA Cardiol; 2017 Sep 01; 2(9):1013-1018. PubMed ID: 28564678
    [Abstract] [Full Text] [Related]

  • 2. Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis.
    Joshi AA, Lerman JB, Dey AK, Sajja AP, Belur AD, Elnabawi YA, Rodante JA, Aberra TM, Chung J, Salahuddin T, Natarajan B, Dave J, Goyal A, Groenendyk JW, Rivers JP, Baumer Y, Teague HL, Playford MP, Bluemke DA, Ahlman MA, Chen MY, Gelfand JM, Mehta NN.
    JAMA Cardiol; 2018 Oct 01; 3(10):949-956. PubMed ID: 30208407
    [Abstract] [Full Text] [Related]

  • 3. Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study.
    Naik HB, Natarajan B, Stansky E, Ahlman MA, Teague H, Salahuddin T, Ng Q, Joshi AA, Krishnamoorthy P, Dave J, Rose SM, Doveikis J, Playford MP, Prussick RB, Ehrlich A, Kaplan MJ, Lockshin BN, Gelfand JM, Mehta NN.
    Arterioscler Thromb Vasc Biol; 2015 Dec 01; 35(12):2667-76. PubMed ID: 26449753
    [Abstract] [Full Text] [Related]

  • 4. Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond Cardiometabolic Disease Risk Factors in an Observational Cohort Study.
    Rivers JP, Powell-Wiley TM, Dey AK, Rodante JA, Chung JH, Joshi AA, Natarajan B, Sajja AP, Chaturvedi A, Rana A, Harrington CL, Teague HL, Lockshin BN, Ahlman MA, Yao J, Playford MP, Gelfand JM, Mehta NN.
    JACC Cardiovasc Imaging; 2018 Feb 01; 11(2 Pt 2):349-357. PubMed ID: 29055628
    [Abstract] [Full Text] [Related]

  • 5. 18F-fluorodeoxyglucose positron emission tomography-based evaluation of systemic and vascular inflammation and assessment of the effect of systemic treatment on inflammation in patients with moderate-to-severe psoriasis: A randomized placebo-controlled pilot study.
    Kaur S, Shafiq N, Dogra S, Mittal BR, Attri SV, Bahl A, Narang T, Vinay K, Rajagopalan S, Malhotra S.
    Indian J Dermatol Venereol Leprol; 2018 Feb 01; 84(6):660-666. PubMed ID: 29893297
    [Abstract] [Full Text] [Related]

  • 6. Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial.
    Bissonnette R, Tardif JC, Harel F, Pressacco J, Bolduc C, Guertin MC.
    Circ Cardiovasc Imaging; 2013 Jan 01; 6(1):83-90. PubMed ID: 23204039
    [Abstract] [Full Text] [Related]

  • 7. Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis.
    Dey AK, Gaddipati R, Elnabawi YA, Ongstad E, Goyal A, Chung JH, Teague HL, Rodante JA, Sajja AA, Sorokin AV, Lateef SS, Aksentijevich M, Choi H, Reddy AS, Varghese NJ, Groenendyk J, Belur AD, Genovese L, Rivers JP, Lerman J, Kabbany MT, Harrington C, Ortiz J, Khalil N, Keel A, Baumer Y, Chen MY, Bluemke DA, Joshi AA, Kaplan MJ, Remaley AT, Playford MP, Karathanasis SK, Gelfand JM, Gupta R, Mehta NN.
    JAMA Dermatol; 2020 Feb 01; 156(2):151-157. PubMed ID: 31746956
    [Abstract] [Full Text] [Related]

  • 8. Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial.
    Mehta NN, Shin DB, Joshi AA, Dey AK, Armstrong AW, Duffin KC, Fuxench ZC, Harrington CL, Hubbard RA, Kalb RE, Menter A, Rader DJ, Reilly MP, Simpson EL, Takeshita J, Torigian DA, Werner TJ, Troxel AB, Tyring SK, Vanderbeek SB, Van Voorhees AS, Playford MP, Ahlman MA, Alavi A, Gelfand JM.
    Circ Cardiovasc Imaging; 2018 Jun 01; 11(6):e007394. PubMed ID: 29776990
    [Abstract] [Full Text] [Related]

  • 9. Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease.
    Eder L, Joshi AA, Dey AK, Cook R, Siegel EL, Gladman DD, Mehta NN.
    Arthritis Rheumatol; 2018 Mar 01; 70(3):408-416. PubMed ID: 29088580
    [Abstract] [Full Text] [Related]

  • 10. Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation Index.
    Elnabawi YA, Oikonomou EK, Dey AK, Mancio J, Rodante JA, Aksentijevich M, Choi H, Keel A, Erb-Alvarez J, Teague HL, Joshi AA, Playford MP, Lockshin B, Choi AD, Gelfand JM, Chen MY, Bluemke DA, Shirodaria C, Antoniades C, Mehta NN.
    JAMA Cardiol; 2019 Sep 01; 4(9):885-891. PubMed ID: 31365032
    [Abstract] [Full Text] [Related]

  • 11. Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study.
    Goyal A, Dey AK, Chaturvedi A, Elnabawi YA, Aberra TM, Chung JH, Belur AD, Groenendyk JW, Lerman JB, Rivers JP, Rodante JA, Harrington CL, Varghese NJ, Sanda GE, Baumer Y, Sorokin AV, Teague HL, Genovese LD, Natarajan B, Joshi AA, Playford MP, Bluemke DA, Chen MY, Alavi A, Pitman RK, Powell-Wiley TM, Tawakol A, Gelfand JM, Mehta NN.
    JACC Cardiovasc Imaging; 2020 Feb 01; 13(2 Pt 1):465-477. PubMed ID: 30448131
    [Abstract] [Full Text] [Related]

  • 12. Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study.
    Groenendyk JW, Shukla P, Dey AK, Elnabawi YA, Aksentijevich M, Choi H, Genovese LD, Harrington CL, Natarajan B, Goyal A, Reddy AS, Rodante J, Kabbany MT, Sadek A, Al Najafi M, Playford MP, Joshi AA, Ahlman MA, Gelfand JM, Bluemke DA, Mehta NN.
    Eur J Nucl Med Mol Imaging; 2019 Nov 01; 46(12):2488-2495. PubMed ID: 31385013
    [Abstract] [Full Text] [Related]

  • 13. Subclinical systemic and vascular inflammation detected by (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with mild psoriasis.
    Youn SW, Kang SY, Kim SA, Park GY, Lee WW.
    J Dermatol; 2015 Jun 01; 42(6):559-66. PubMed ID: 25807844
    [Abstract] [Full Text] [Related]

  • 14. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.
    Mehta NN, Yu Y, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM.
    Arch Dermatol; 2011 Sep 01; 147(9):1031-9. PubMed ID: 21576552
    [Abstract] [Full Text] [Related]

  • 15. Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: Feasibility study using 18F-fluorodeoxyglucose PET/CT.
    Kim BS, Lee WK, Pak K, Han J, Kim GW, Kim HS, Ko HC, Kim MB, Kim SJ.
    J Am Acad Dermatol; 2019 May 01; 80(5):1322-1331. PubMed ID: 29559399
    [Abstract] [Full Text] [Related]

  • 16. Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis.
    Hjuler KF, Gormsen LC, Vendelbo MH, Egeberg A, Nielsen J, Iversen L.
    Br J Dermatol; 2017 Mar 01; 176(3):732-740. PubMed ID: 27787888
    [Abstract] [Full Text] [Related]

  • 17. The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events.
    Egeberg A, Skov L, Joshi AA, Mallbris L, Gislason GH, Wu JJ, Rodante J, Lerman JB, Ahlman MA, Gelfand JM, Mehta NN.
    J Am Acad Dermatol; 2017 Oct 01; 77(4):650-656.e3. PubMed ID: 28826925
    [Abstract] [Full Text] [Related]

  • 18. Systemic Inflammation and Evidence of a Cardio-splenic Axis in Patients with Psoriasis.
    Hjuler KF, Gormsen LC, Vendelbo MH, Egeberg A, Nielsen J, Iversen L.
    Acta Derm Venereol; 2018 Apr 16; 98(4):390-395. PubMed ID: 29327063
    [Abstract] [Full Text] [Related]

  • 19. Association Between Quality of Life and Improvement in Psoriasis Severity and Extent in Pediatric Patients.
    Bruins FM, Bronckers IMGJ, Groenewoud HMM, van de Kerkhof PCM, de Jong EMGJ, Seyger MMB.
    JAMA Dermatol; 2020 Jan 01; 156(1):72-78. PubMed ID: 31774449
    [Abstract] [Full Text] [Related]

  • 20. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2010 Dec 01; 11(6):423-32. PubMed ID: 20429617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.